orphagen.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
# START YOAST BLOCK # --------------------------- User-agent: * Disallow: Sitemap: https://www.orphagen.com/sitemap_index.xml # --------------------------- # END YOAST
Meta Tags
Title Orphagen Pharmaceuticals - Small Molecule Medicine
Description Small molecule drug Orphagen Pharmaceuticals are leaders in the screening of ligands that modulate orphan nuclear receptors for the discovery of novel
Keywords N/A
Server Information
WebSite orphagen faviconorphagen.com
Host IP 69.163.154.181
Location United States
Related Websites
Site Rank
More to Explore
orphagen.com Valuation
US$1,798,154
Last updated: 2023-05-09 12:56:45

orphagen.com has Semrush global rank of 5,886,206. orphagen.com has an estimated worth of US$ 1,798,154, based on its estimated Ads revenue. orphagen.com receives approximately 207,480 unique visitors each day. Its web server is located in United States, with IP address 69.163.154.181. According to SiteAdvisor, orphagen.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$1,798,154
Daily Ads Revenue US$1,660
Monthly Ads Revenue US$49,796
Yearly Ads Revenue US$597,541
Daily Unique Visitors 13,832
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
orphagen.com. A 299 IP: 69.163.154.181
orphagen.com. NS 300 NS Record: dns102.register.com.
orphagen.com. NS 300 NS Record: dns101.register.com.
orphagen.com. MX 300 MX Record: 10 orphagen-com.mail.protection.outlook.com.
orphagen.com. TXT 300 TXT Record: v=spf1 include:spf.protection.outlook.com -all
HtmlToTextCheckTime:2023-05-09 12:56:45
Home Team Pipeline Adrenocortical Cancer (ACC) Gut Inflammation and IBD Novel/Undisclosed Targets Our Science News Contact Select Page Small molecule drug discovery Breakthrough therapies for inflammatory disease and oncology Who We Are: Orphagen is a pioneer in the screening, discovery and development of ligands that modulate orphan or unexplored members of the nuclear receptor family. We have proprietary small molecule leads and candidates for novel drug targets with potential applications in inflammatory disease and oncology. Orphagen Team Our scientists and management team are committed to the best we can bring to bear in pursuit of new therapies. We are drug hunters. . Read More PIPELINE Our mission is translational drug discovery and development with novel targets leading to first in class therapeutics. Read More Designed by Elegant Themes | Powered by
HTTP Headers
HTTP/1.1 301 Moved Permanently
Date: Sun, 31 Oct 2021 21:50:50 GMT
Server: Apache
Location: https://www.orphagen.com/
Content-Type: text/html; charset=iso-8859-1

HTTP/2 200 
date: Sun, 31 Oct 2021 21:50:50 GMT
server: Apache
x-pingback: https://www.orphagen.com/xmlrpc.php
link: ; rel="https://api.w.org/", ; rel="alternate"; type="application/json", ; rel=shortlink
cache-control: max-age=600
expires: Sun, 31 Oct 2021 22:00:50 GMT
vary: User-Agent
content-type: text/html; charset=UTF-8
orphagen.com Whois Information
Domain Name: ORPHAGEN.COM
Registry Domain ID: 31078661_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.register.com
Registrar URL: http://www.register.com
Updated Date: 2020-03-27T03:44:49Z
Creation Date: 2000-07-08T21:46:14Z
Registry Expiry Date: 2022-07-08T21:46:14Z
Registrar: Register.com, Inc.
Registrar IANA ID: 9
Registrar Abuse Contact Email: abuse@web.com
Registrar Abuse Contact Phone: +1.8003337680
Domain Status: ok https://icann.org/epp#ok
Name Server: DNS101.REGISTER.COM
Name Server: DNS102.REGISTER.COM
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-19T07:35:40Z <<<